Dian Diagnostics Group Co.,Ltd. (SHE:300244)

China · Delayed Price · Currency is CNY

18.26

-2.92 (-13.79%)

Jul 17, 2026, 3:04 PM CST

20.21% (1Y)

Market Cap	11.16B +20.2%
Revenue (ttm)	9.98B -13.9%
Net Income	129.43M
EPS	0.21
Shares Out	611.10M
PE Ratio	86.22
Forward PE	27.34
Dividend	0.35 (1.92%)
Ex-Dividend Date	Jun 25, 2026

Volume	60,118,334
Open	20.77
Previous Close	21.18
Day's Range	18.23 - 20.91
52-Week Range	14.48 - 33.30
Beta	0.69
Analysts	Buy
Price Target	18.84 (+3.18%)
Earnings Date	Aug 21, 2026

About Dian Diagnostics Group

Dian Diagnostics Group Co.,Ltd. provides integrated medical diagnostics solutions with independent diagnostic services in China. The company offers laboratory supplies and kits; AI-assisted digital pathology diagnosis solutions, such as nucleic acid extraction and purification system, automatic liquid-based cytology slide preparation and staining system, digital pathology slide scanner, automated pathology slide staining system, genotyping DNA test kit, human papillomavirus nucleic acid detection kit, PCR system and detection system, and virus... [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 1996

Employees 7,462

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300244

Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 8 analysts, the average rating for 300244 stock is "Buy." The 12-month stock price target is ¥18.84, which is an increase of 3.18% from the latest price.

Price Target

¥18.84

(3.18% upside)

Analyst Consensus: Buy

Stock Forecasts